坤泰胶囊与芬吗通联合治疗对更年期综合征患者性激素水平、睡眠状况的影响
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R711.75

基金项目:

金华市公益性技术应用研究项目(金市科〔2022〕40号)


Effect of Kuntai Capsules Combined with Femoston on Sex Hormone Levels and Sleep Status of Patients with Menopausal Syndrome
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察坤泰胶囊与芬吗通联合治疗更年期综合征(CS) 的临床疗效。方法:将90 例CS 患者 随机分为常规组与研究组各45 例,常规组给予芬吗通治疗,研究组给予芬吗通与坤泰胶囊联合治疗。比较 2 组治疗前后性激素水平、改良Kupperman 评分、睡眠情况及治疗后临床疗效。结果:治疗前,2 组卵泡刺激 素(FSH)、雌二醇(E2)、促黄体生成激素(LH) 水平比较,差异无统计学意义(P>0.05);治疗后,2 组 FSH、LH 水平均降低(P<0.05),E2 水平均升高(P<0.05),且研究组FSH、LH 水平低于常规组(P< 0.05),E2 水平高于常规组(P<0.05)。治疗前,2 组睡眠时间、入睡时间比较,差异无统计学意义(P> 0.05);治疗后,2 组睡眠时间延长(P<0.05),入睡时间缩短(P<0.05),且研究组睡眠时间长于常规 组(P<0.05),入睡时间短于常规组(P<0.05)。治疗前,2 组改良Kupperman 评分比较,差异无统计学意 义(P>0.05);治疗后2 组改良Kupperman 评分均降低(P<0.05),且研究组低于常规组(P<0.05)。治疗 后,研究组治疗总有效率88.89%,高于常规组71.11%(P<0.05)。治疗期间2 组均未出现明显不良反应。结 论:坤泰胶囊与芬吗通联合治疗女性CS 可调节性激素分泌,改善患者临床症状,疗效安全、可靠。

    Abstract:

    Abstract: Objective: To observe the clinical effect of Kuntai Capsules combined with Femoston for menopause syndrome (CS). Methods: A total of 90 cases of CS patients were randomly divided into the routine group and the study group, with 45 cases in each group. The routine group was treated with Femoston,and the study group was treated with Femoston combined with Kuntai Capsules. Sex hormone levels,modified Kupperman scores and sleep status before and after treatment as well as clinical effects after treatment were compared between the two groups. Results: Before treatment, there was no significant difference being found in the comparison of the levels of follicle- stimulating hormones (FSH), estradiol (E2) and luteinizing hormone (LH) between the two groups (P>0.05);after treatment,the levels of FSH and LH in the two groups were decreased (P<0.05),and the levels of E2 were increased (P<0.05); the levels of FSH and LH in the study group were lower than those in the routine group (P<0.05),and the level of E2 was higher than that in the routine group (P<0.05). Before treatment,there was no significant difference being found in the comparison of sleep time and time for falling asleep between the two groups (P>0.05);after treatment,the sleep time in the two groups was prolonged and the time for falling asleep was shortened (P<0.05);the sleep time in the study group was longer than that in the routine group (P< 0.05), and the time for falling asleep was shorter than that in the routine group (P<0.05). Before treatment, there was no significant difference being found in the comparison of modified Kupperman scores between the two groups (P>0.05);after treatment,modified Kupperman scores in the two groups were decreased (P<0.05),and the score in the study group was lower than that in the routine group (P< 0.05). After treatment,the total effective rate was 88.89% in the study group,higher than that of 71.11% in the routine group (P<0.05). During the treatment,there were no obvious adverse reactions in the two groups. Conclusion:Kuntai Capsules combined with Femoston for CS in female can regulate the secretion of sex hormones and improve the clinical symptoms of patients,with a safe and reliable curative effect.

    参考文献
    相似文献
    引证文献
引用本文

厉姗姗,刘杰,张安.坤泰胶囊与芬吗通联合治疗对更年期综合征患者性激素水平、睡眠状况的影响[J].新中医,2023,55(3):118-121

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-02-17
  • 出版日期:
文章二维码